- Home
- PROF vs DRTS Comparison
PROF vs DRTS Comparison
Compare PROF & DRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROF
- DRTS
- Stock Information
- Founded
- PROF N/A
- DRTS 2015
- Country
- PROF Canada
- DRTS Israel
- Employees
- PROF N/A
- DRTS N/A
- Industry
- PROF Medical/Dental Instruments
- DRTS Medical/Dental Instruments
- Sector
- PROF Health Care
- DRTS Health Care
- Exchange
- PROF Nasdaq
- DRTS Nasdaq
- Market Cap
- PROF 140.9M
- DRTS 211.7M
- IPO Year
- PROF N/A
- DRTS N/A
- Fundamental
- Price
- PROF $4.98
- DRTS $2.92
- Analyst Decision
- PROF Strong Buy
- DRTS Strong Buy
- Analyst Count
- PROF 2
- DRTS 2
- Target Price
- PROF $11.50
- DRTS $8.00
- AVG Volume (30 Days)
- PROF 72.4K
- DRTS 27.2K
- Earning Date
- PROF 05-08-2025
- DRTS 05-19-2025
- Dividend Yield
- PROF N/A
- DRTS N/A
- EPS Growth
- PROF N/A
- DRTS N/A
- EPS
- PROF N/A
- DRTS N/A
- Revenue
- PROF $10,680,000.00
- DRTS N/A
- Revenue This Year
- PROF $71.17
- DRTS N/A
- Revenue Next Year
- PROF $134.25
- DRTS N/A
- P/E Ratio
- PROF N/A
- DRTS N/A
- Revenue Growth
- PROF 48.35
- DRTS N/A
- 52 Week Low
- PROF $3.90
- DRTS $1.75
- 52 Week High
- PROF $11.42
- DRTS $4.39
- Technical
- Relative Strength Index (RSI)
- PROF 46.29
- DRTS 67.20
- Support Level
- PROF $4.62
- DRTS $2.50
- Resistance Level
- PROF $5.62
- DRTS $2.67
- Average True Range (ATR)
- PROF 0.39
- DRTS 0.14
- MACD
- PROF 0.09
- DRTS 0.03
- Stochastic Oscillator
- PROF 46.51
- DRTS 91.30
About PROF Profound Medical Corp.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.
About DRTS Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. The Alpha CaRT technology of the company utilizes the therapeutic properties of alpha particles aiming to overcome, and harness for benefit for alpha radiation's range. The company derives maximum revenue from Israel.